While the RAET ligands can signal immune recognition of cancer cells, it is likely that immunosuppression within the microenvironment prevents effective RAET signaling in TCPTC, and the upregulation of NKG2D ligands have been linked to poor prognoses in other cancers [30,31]. The gene discussed is KLRK1; the disease is cancer.